PROF Profound Medical Total Debt to Capital

PROF (profoundmedical.com) - company brandmark

Profound Medical Corp. (PROF) relies on contract manufacturing of hardware components and a cloud service to support MRI-guided therapy. High margins are driven by locking clinics into proprietary software and consumables through staff training. The standalone debt-to-equity ratio is 0.15. The price action reflected on this chart complements data regarding a stable R&D engineering staff and the recruitment of specialized sales experts.

Profound Medical Corporation - PROF Debt to Capital (period 07/04/2022 - 10/27/2026)
Finished products of Profound Medical Corp

For Profound Medical Corp. (PROF), this indicator determines the extent to which the medical business relies on external financing relative to its own resources. The metric compares total liabilities to equity, identifying insolvency risks in a rising rate environment. By analyzing the trend of the company's total liabilities-to-equity ratio, an investor assesses financial stability. The absence of M&A plans and a focus on the organic deployment of systems in clinics minimize the need for debt loans. This ensures a stable balance between growth and solvency.

Analysis of competing companies

Dexcom (DXCM) - Total Debt to Equity Ratio|Aggregate Debt to Capital Penumbra Inc|Novanta Corp (NOVT) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Haemonetics Company (HAE)|INSP: Total Debt to Capital|procept-biorobotics.com - Debt to Capital|Debt to Equity CONMED (CNMD)|PLSE - All Debt to Shareholders' Equity Ratio|INMD: Total Debt to Capital|PMI (Picard Group) - Total Debt to Capital|Debt to Equity Surmodics, Inc. SRDX|Aggregate Debt to Equity Senseonics Corp|NeuroPace - Total Debt to Capital|Debt to Capital tactilemedical.com TCMD|Total Debt to Equity Ratio SNWV (SANUWAVE Health, Inc.)|OM - Total Debt to Capital|Total Debt to Equity Ratio Electromed Inc ELMD|LNSR - Aggregate Debt to Capital|AVITA Medical - Total Debt to Capital|Baird Medical (BDMD) - Total Debt to Capital Coefficient|Total Debt to Capital EDAP|Total Debt to Equity Ratio Bovie Medical (APYX)|IceCure Medical Ltd (ICCM) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio LUNG (pulmonx.com)|TELA Bio - Debt to Equity|Total Debt to Equity Ratio CytoSorbents Corp CTSO|SRTS (Sensus Healthcare Corp) - Total Debt to Capital|ZYXI - Debt to Capital|Total Debt to Capital electrocore.com|Vicarious Surgical (RBOT) - Debt to Equity Ratio|IINN: Total Debt to Capital|Total Debt to Capital Coefficient SeaStar Medical Holding Corporation|Total Debt to Capital IRIX (IRIDEX Corporation)|Total Debt to Equity Ratio ibs.inc (INBS)|Total Debt to Capital XAIR (Beyond Air)|profusa.com - Total Debt to Capital|SSKN - Debt to Equity|glucotrack.com (GCTK) - Debt to Equity|Total Debt to Equity Ratio NanoVibronix NAOV|Venus Concept Corporation (VERO) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital NUWE (Nuwellis, Inc.)|Debt to Capital AEMD|ASXC: Debt to Equity|Debt to Capital Ratio Avinger Inc. AVGR|Total Debt to Equity Ratio BSGM (BioSig Technologies, Inc.)|Total Debt to Capital Cutera Inc CUTR|Total Debt to Capital KNW (Know Labs, Inc.)|NARI: Total Debt to Capital Coefficient|Debt to Equity Nevro (NVRO)|RSLS (ReShape Lifesciences Inc.) - Aggregate Debt to Equity|Debt to Equity SILK